Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cancer Genetics

4.61
+0.0000
Volume:- -
Turnover:- -
Market Cap:48.69M
PE:-2.23
High:4.61
Open:4.61
Low:4.61
Close:4.61
Loading ...
Apr 05, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2021

Major Issues Report

8-K - Current report
Mar 25, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Mar 16, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 26, 2021

Major Issues Report

8-K - Current report
Feb 26, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 25, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report